261 related articles for article (PubMed ID: 27057733)
1. Atp13a2 expression in the periaqueductal gray is decreased in the Pink1 -/- rat model of Parkinson disease.
Kelm-Nelson CA; Stevenson SA; Ciucci MR
Neurosci Lett; 2016 May; 621():75-82. PubMed ID: 27057733
[TBL] [Abstract][Full Text] [Related]
2. Gene expression within the periaqueductal gray is linked to vocal behavior and early-onset parkinsonism in Pink1 knockout rats.
Kelm-Nelson CA; Gammie S
BMC Genomics; 2020 Sep; 21(1):625. PubMed ID: 32942992
[TBL] [Abstract][Full Text] [Related]
3. Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease.
Grant LM; Kelm-Nelson CA; Hilby BL; Blue KV; Paul Rajamanickam ES; Pultorak JD; Fleming SM; Ciucci MR
J Neurosci Res; 2015 Nov; 93(11):1713-27. PubMed ID: 26234713
[TBL] [Abstract][Full Text] [Related]
4. Intervention changes acoustic peak frequency and mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease.
Stevenson SA; Ciucci MR; Kelm-Nelson CA
PLoS One; 2019; 14(8):e0220734. PubMed ID: 31374106
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ
Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191
[TBL] [Abstract][Full Text] [Related]
6. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
7. Changes to Ventilation, Vocalization, and Thermal Nociception in the Pink1-/- Rat Model of Parkinson's Disease.
Johnson RA; Kelm-Nelson CA; Ciucci MR
J Parkinsons Dis; 2020; 10(2):489-504. PubMed ID: 32065805
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal impairment in Parkinson's disease.
Dehay B; Martinez-Vicente M; Caldwell GA; Caldwell KA; Yue Z; Cookson MR; Klein C; Vila M; Bezard E
Mov Disord; 2013 Jun; 28(6):725-32. PubMed ID: 23580333
[TBL] [Abstract][Full Text] [Related]
9. Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats.
Creed RB; Roberts RC; Farmer CB; McMahon LL; Goldberg MS
Neurobiol Dis; 2021 Mar; 150():105246. PubMed ID: 33387634
[TBL] [Abstract][Full Text] [Related]
10. Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.
Kelm-Nelson CA; Brauer AFL; Barth KJ; Lake JM; Sinnen MLK; Stehula FJ; Muslu C; Marongiu R; Kaplitt MG; Ciucci MR
Brain Res; 2018 Feb; 1680():1-12. PubMed ID: 29229503
[TBL] [Abstract][Full Text] [Related]
11. Early-onset Parkinsonian behaviors in female Pink1-/- rats.
Marquis JM; Lettenberger SE; Kelm-Nelson CA
Behav Brain Res; 2020 Jan; 377():112175. PubMed ID: 31542395
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils.
Creed RB; Goldberg MS
Neuroscience; 2020 Jun; 437():64-75. PubMed ID: 32353461
[TBL] [Abstract][Full Text] [Related]
13. Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.
Orr AL; Rutaganira FU; de Roulet D; Huang EJ; Hertz NT; Shokat KM; Nakamura K
Neurochem Int; 2017 Oct; 109():106-116. PubMed ID: 28434973
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of extrinsic tongue muscles in the Pink1-/- rat model of Parkinson disease.
Glass TJ; Kelm-Nelson CA; Szot JC; Lake JM; Connor NP; Ciucci MR
PLoS One; 2020; 15(10):e0240366. PubMed ID: 33064741
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
Kong SM; Chan BK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA
Hum Mol Genet; 2014 Jun; 23(11):2816-33. PubMed ID: 24603074
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease.
Hoffmeister JD; Kelm-Nelson CA; Ciucci MR
Behav Brain Res; 2022 Feb; 418():113642. PubMed ID: 34755639
[TBL] [Abstract][Full Text] [Related]
17. In search of early neuroradiological biomarkers for Parkinson's Disease: Alterations in resting state functional connectivity and gray matter microarchitecture in PINK1 -/- rats.
Cai X; Qiao J; Knox T; Iriah S; Kulkarni P; Madularu D; Morrison T; Waszczak B; Hartner JC; Ferris CF
Brain Res; 2019 Mar; 1706():58-67. PubMed ID: 30389398
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young mice.
Johnson ME; Bergkvist L; Stetzik L; Steiner JA; Meyerdirk L; Schulz E; Wolfrum E; Luk KC; Wesson DW; Krainc D; Brundin P
Neurobiol Dis; 2021 Nov; 159():105513. PubMed ID: 34536552
[TBL] [Abstract][Full Text] [Related]
19. Pink1 -/- Rats Show Early-Onset Swallowing Deficits and Correlative Brainstem Pathology.
Cullen KP; Grant LM; Kelm-Nelson CA; Brauer AFL; Bickelhaupt LB; Russell JA; Ciucci MR
Dysphagia; 2018 Dec; 33(6):749-758. PubMed ID: 29713896
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice.
Oliveras-Salvá M; Macchi F; Coessens V; Deleersnijder A; Gérard M; Van der Perren A; Van den Haute C; Baekelandt V
Neurobiol Aging; 2014 Nov; 35(11):2625-2636. PubMed ID: 25037286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
